• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对 COVID-19 危重症患者通气管理和临床结局的影响——来自 PRoVENT-COVID 研究的观察。

The effect of age on ventilation management and clinical outcomes in critically ill COVID-19 patients--insights from the PRoVENT-COVID study.

机构信息

Department of Anesthesiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.

Department of Intensive Care, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.

出版信息

Aging (Albany NY). 2022 Jan 31;14(3):1087-1109. doi: 10.18632/aging.203863.

DOI:10.18632/aging.203863
PMID:35100136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8876900/
Abstract

INTRODUCTION

We analyzed the association of age with ventilation practice and outcomes in critically ill COVID-19 patients requiring invasive ventilation.

METHODS

Posthoc analysis of the PRoVENT-COVID study, an observational study performed in 22 ICUs in the first 3 months of the national outbreak in the Netherlands. The coprimary endpoint was a set of ventilator parameters, including tidal volume normalized for predicted bodyweight, positive end-expiratory pressure, driving pressure, and respiratory system compliance in the first 4 days of invasive ventilation. Secondary endpoints were other ventilation parameters, the use of rescue therapies, pulmonary and extrapulmonary complications in the first 28 days in the ICU, hospital- and ICU stay, and mortality.

RESULTS

1122 patients were divided into four groups based on age quartiles. No meaningful differences were found in ventilation parameters and in the use of rescue therapies for refractory hypoxemia in the first 4 days of invasive ventilation. Older patients received more often a tracheostomy, developed more frequently acute kidney injury and myocardial infarction, stayed longer in hospital and ICU, and had a higher mortality.

CONCLUSIONS

In this cohort of invasively ventilated critically ill COVID-19 patients, age had no effect on ventilator management. Higher age was associated with more complications, longer length of stay in ICU and hospital and a higher mortality.

摘要

简介

我们分析了年龄与 COVID-19 危重症患者接受有创通气时通气实践和结局的关系。

方法

对 PRoVENT-COVID 研究的事后分析,该观察性研究在荷兰全国疫情爆发的头 3 个月内在 22 个 ICU 进行。主要终点是一组通气参数,包括有创通气的前 4 天内潮气量与预测体重的比值、呼气末正压、驱动压和呼吸系统顺应性。次要终点是其他通气参数、在有创通气的前 28 天内使用抢救治疗、肺和肺外并发症、住院和 ICU 住院时间以及死亡率。

结果

根据年龄四分位数将 1122 名患者分为四组。在前 4 天的有创通气中,在通气参数和治疗难治性低氧血症的抢救治疗方面,各组之间没有明显差异。老年患者更常接受气管切开术,更常发生急性肾损伤和心肌梗死,住院和 ICU 停留时间更长,死亡率更高。

结论

在本队列中,接受有创通气的 COVID-19 危重症患者中,年龄对通气管理没有影响。年龄较大与更多并发症、更长的 ICU 和住院时间以及更高的死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46b/8876900/91e7d9198c53/aging-14-203863-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46b/8876900/c34d70682fad/aging-14-203863-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46b/8876900/91e7d9198c53/aging-14-203863-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46b/8876900/c34d70682fad/aging-14-203863-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46b/8876900/91e7d9198c53/aging-14-203863-g002.jpg

相似文献

1
The effect of age on ventilation management and clinical outcomes in critically ill COVID-19 patients--insights from the PRoVENT-COVID study.年龄对 COVID-19 危重症患者通气管理和临床结局的影响——来自 PRoVENT-COVID 研究的观察。
Aging (Albany NY). 2022 Jan 31;14(3):1087-1109. doi: 10.18632/aging.203863.
2
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study.COVID-19 有创通气患者的通气管理和临床结局(PRoVENT-COVID):一项全国性、多中心、观察性队列研究。
Lancet Respir Med. 2021 Feb;9(2):139-148. doi: 10.1016/S2213-2600(20)30459-8. Epub 2020 Oct 23.
3
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.阿根廷 COVID-19 有创通气患者的临床特征和结局(SATICOVID):一项前瞻性、多中心队列研究。
Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.
4
Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study.通气强度与 COVID-19 急性呼吸衰竭患者 28 天死亡率的关系:来自 PRoVENT-COVID 研究的见解。
Crit Care. 2021 Aug 6;25(1):283. doi: 10.1186/s13054-021-03710-6.
5
Hyperoxemia in invasively ventilated COVID-19 patients-Insights from the PRoVENT-COVID study.有创通气的新冠病毒肺炎患者的高氧血症——来自PRoVENT-COVID研究的见解
Pulmonology. 2024 May-Jun;30(3):272-281. doi: 10.1016/j.pulmoe.2022.09.003. Epub 2022 Sep 15.
6
PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands.新型冠状病毒病患者通气实践(PRoVENT-COVID):荷兰一项全国多中心观察性研究的原理与方案
Ann Transl Med. 2020 Oct;8(19):1251. doi: 10.21037/atm-20-5107.
7
Practice of tracheostomy in patients with acute respiratory failure related to COVID-19 - Insights from the PRoVENT-COVID study.COVID-19 相关急性呼吸衰竭患者的气管切开术实践——来自 PRoVENT-COVID 研究的见解。
Pulmonology. 2022 Jan-Feb;28(1):18-27. doi: 10.1016/j.pulmoe.2021.08.012. Epub 2021 Sep 20.
8
Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19---insights from the PRoVENT-COVID study.COVID-19 所致急性低氧性呼吸衰竭患者高碳酸血症的临床特征、生理特征及结局:来自 PRoVENT-COVID 研究的观察。
J Crit Care. 2022 Jun;69:154022. doi: 10.1016/j.jcrc.2022.154022. Epub 2022 Mar 24.
9
Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.16 个国家重症监护病房急性呼吸窘迫综合征高危患者的流行病学特征、通气实践和临床转归(PRoVENT):一项国际多中心前瞻性研究。
Lancet Respir Med. 2016 Nov;4(11):882-893. doi: 10.1016/S2213-2600(16)30305-8. Epub 2016 Oct 4.
10
The clinical course of critically ill COVID-19 patients receiving invasive mechanical ventilation with subsequent terminal weaning: Primary data from 11 cases.COVID-19 危重症患者接受有创机械通气后进行终末撤机的临床过程:11 例的原始数据。
Medicine (Baltimore). 2021 Apr 23;100(16):e25619. doi: 10.1097/MD.0000000000025619.

引用本文的文献

1
Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19.托珠单抗可降低 COVID-19 重症患者的谵妄和昏迷发生率。
Sci Rep. 2024 May 23;14(1):11738. doi: 10.1038/s41598-024-62505-1.
2
Age and Comorbidity Profiles as Predictors of Mechanical Ventilation Duration in COVID-19 ICU Patients: A Retrospective Study in Saudi Arabia.年龄和合并症情况作为新冠病毒肺炎重症监护病房患者机械通气持续时间的预测因素:沙特阿拉伯的一项回顾性研究
Cureus. 2024 Jan 26;16(1):e52976. doi: 10.7759/cureus.52976. eCollection 2024 Jan.
3
Outcomes comparison between the first and the subsequent SARS-CoV-2 waves - a systematic review and meta-analysis.

本文引用的文献

1
The importance of revealing data on limitation of life sustaining therapy in critical ill elderly Covid-19 patients.揭示危重症老年新冠患者生命维持治疗局限性数据的重要性。
J Crit Care. 2022 Feb;67:147-148. doi: 10.1016/j.jcrc.2021.10.024. Epub 2021 Nov 12.
2
Differences in mortality in critically ill elderly patients during the second COVID-19 surge in Europe.欧洲第二波 COVID-19 期间危重症老年患者死亡率的差异。
Crit Care. 2021 Sep 23;25(1):344. doi: 10.1186/s13054-021-03739-7.
3
Prediction of 28-day mortality in critically ill patients with COVID-19: Development and internal validation of a clinical prediction model.
新型冠状病毒(SARS-CoV-2)第一波和后续波次疫情的结局比较——一项系统评价与荟萃分析
Multidiscip Respir Med. 2023 Nov 2;18(1):933. doi: 10.4081/mrm.2023.933. eCollection 2023 Jan 17.
4
The obesity paradox in Japanese COVID-19 patients.日本 COVID-19 患者中的肥胖悖论。
Int J Med Sci. 2023 Sep 11;20(11):1508-1512. doi: 10.7150/ijms.86933. eCollection 2023.
5
Longitudinal assessment of demographic representativeness in the Medical Imaging and Data Resource Center open data commons.医学影像与数据资源中心开放数据共享库中人口统计学代表性的纵向评估。
J Med Imaging (Bellingham). 2023 Nov;10(6):61105. doi: 10.1117/1.JMI.10.6.061105. Epub 2023 Jul 18.
6
Age and sex differentially shape brain networks in Parkinson's disease.年龄和性别差异塑造帕金森病的大脑网络。
CNS Neurosci Ther. 2023 Jul;29(7):1907-1922. doi: 10.1111/cns.14149. Epub 2023 Mar 8.
预测 COVID-19 重症患者 28 天死亡率:临床预测模型的建立与内部验证。
PLoS One. 2021 Jul 13;16(7):e0254550. doi: 10.1371/journal.pone.0254550. eCollection 2021.
4
The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study.COVID-19 老年重症监护患者衰弱对生存的影响:COVIP 研究。
Crit Care. 2021 Apr 19;25(1):149. doi: 10.1186/s13054-021-03551-3.
5
Long-term mortality of elderly patients after intensive care unit admission for COVID-19.COVID-19患者入住重症监护病房后老年患者的长期死亡率。
Intensive Care Med. 2021 Jun;47(6):710-712. doi: 10.1007/s00134-021-06399-x. Epub 2021 Apr 12.
6
Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19-Insights from the PRoVENT-COVID Study.体重指数与2019冠状病毒病相关急性呼吸窘迫综合征有创通气患者通气管理及临床结局的关联——来自PRoVENT-COVID研究的见解
J Clin Med. 2021 Mar 11;10(6):1176. doi: 10.3390/jcm10061176.
7
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局:一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.
8
PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands.新型冠状病毒病患者通气实践(PRoVENT-COVID):荷兰一项全国多中心观察性研究的原理与方案
Ann Transl Med. 2020 Oct;8(19):1251. doi: 10.21037/atm-20-5107.
9
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study.COVID-19 有创通气患者的通气管理和临床结局(PRoVENT-COVID):一项全国性、多中心、观察性队列研究。
Lancet Respir Med. 2021 Feb;9(2):139-148. doi: 10.1016/S2213-2600(20)30459-8. Epub 2020 Oct 23.
10
COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.COVID-19 重症监护中的情况:英格兰、威尔士和北爱尔兰首次疫情流行的流行病学。
Intensive Care Med. 2020 Nov;46(11):2035-2047. doi: 10.1007/s00134-020-06267-0. Epub 2020 Oct 9.